<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Dystonia</journal-id>
<journal-title>Dystonia</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Dystonia</abbrev-journal-title>
<issn pub-type="epub">2813-2106</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">11693</article-id>
<article-id pub-id-type="doi">10.3389/dyst.2024.11693</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Health Archive</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>&#x3b5;-sarcoglycan</italic> myoclonus-dystonia&#x2014;overview of neurophysiological, behavioral, and imaging characteristics</article-title>
<alt-title alt-title-type="left-running-head">Hamami et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/dyst.2024.11693">10.3389/dyst.2024.11693</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hamami</surname>
<given-names>Feline</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2320926/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gerkensmeier</surname>
<given-names>Skadi</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>M&#xfc;nchau</surname>
<given-names>Alexander</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Weissbach</surname>
<given-names>Anne</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff>
<institution>Institute of Systems Motor Science</institution>, <institution>Center of Brain, Behavior and Metabolism (CBBM)</institution>, <institution>University of L&#xfc;beck</institution>, <addr-line>L&#xfc;beck</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1217406/overview">Jan K. Teller</ext-link>, Scientific Advisors International, Poland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Anne Weissbach, <email>anne.weissbach@uni-luebeck.de</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>3</volume>
<elocation-id>11693</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Hamami, Gerkensmeier, M&#xfc;nchau and Weissbach.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Hamami, Gerkensmeier, M&#xfc;nchau and Weissbach</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Myoclonus-Dystonia is a rare, neurological movement disorder, clinically characterized by myoclonic jerks and dystonic symptoms, such as cervical dystonia and writer&#x2019;s cramp. Psychiatric symptoms, like anxiety, depression, and addiction, are frequently reported. Monogenic Myoclonus-Dystonia is mostly caused by pathogenic variants in the <italic>&#x3b5;-sarcoglycan</italic> gene, which is among other regions highly expressed in the cerebellum. The current pharmacological treatment is not satisfactory. Neurophysiological and imaging studies in this patient population are scarce with partly heterogeneous results and sometimes important limitations. However, some studies point towards subcortical alterations, e.g., of the cerebellum and its connections. Further studies addressing previous limitations are important for a better understanding of the underlying pathology of Myoclonus-Dystonia and might build a bridge for the development of future treatment.</p>
</abstract>
<kwd-group>
<kwd>dystonia</kwd>
<kwd>cerebellum</kwd>
<kwd>neurophysiology</kwd>
<kwd>SGCE</kwd>
<kwd>myoclonus</kwd>
</kwd-group>
<contract-sponsor id="cn001">Dystonia Medical Research Foundation<named-content content-type="fundref-id">10.13039/100001595</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Myoclonus-Dystonia (M-D) is a rare, childhood-onset movement disorder characterized by myoclonic jerks predominantly in the upper body, and dystonia, mostly cervical dystonia and writer&#x2019;s cramp [<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B4">4</xref>]. Motor symptoms are often alcohol responsive [<xref ref-type="bibr" rid="B5">5</xref>]. M-D is often associated with psychiatric symptoms, such as anxiety [<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>], obsessive compulsive disorders [<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>], depression [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>], and alcohol abuse/dependence [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>], which can also be present in unaffected mutation carriers [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B17">17</xref>].</p>
<p>The most frequent cause of M-D are pathogenic variants (mostly loss-of-function) in the <italic>&#x3b5;-sarcoglycan</italic> gene (<italic>SGCE</italic>) (OMIM &#x23;159900, DYT11) [<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B21">21</xref>]. <italic>SGCE</italic>-positive M-D is inherited in an autosomal-dominant manner with maternal imprinting, resulting in reduced penetrance [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>]. Thus, &#x223c;95% of <italic>SGCE</italic> mutation carriers, whose variant is maternally inherited, are unaffected, but nearly all mutation carriers, who inherit their variant paternally, develop symptoms [<xref ref-type="bibr" rid="B24">24</xref>].</p>
<p>
<italic>SGCE</italic> is widely expressed in the brain, but different isoforms of <italic>SGCE</italic> appear in a differential expression pattern [<xref ref-type="bibr" rid="B25">25</xref>]. The brain-specific isoform is highly expressed in the cerebellum [<xref ref-type="bibr" rid="B25">25</xref>].</p>
<p>Unfortunately, pharmacological treatment of M-D is mostly not satisfactory [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>] and/or has intolerable side effects [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>].</p>
<p>An important treatment option is deep brain stimulation (DBS) of the globus pallidus internus (GPi) and the thalamus (ventral intermediate nucleus, VIM), which can significantly improve myoclonus and dystonia [<xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B37">37</xref>]. However, several patients are not eligible for DBS or are too afraid of the side effects [<xref ref-type="bibr" rid="B33">33</xref>].</p>
<p>This lack of fully satisfactory and causally effective treatment options highlights the need for further research to better understand underlying disease mechanisms.</p>
<p>Neurophysiological, behavioral, and imaging studies in these patient population are scarce. It has been proposed, that <italic>SGCE</italic>-positive M-D is a network disorder with the cerebellum and its connections as an important hub [<xref ref-type="bibr" rid="B38">38</xref>]. The following is an overview of the state of research on subcortical alterations in M-D. It illustrates limitations but also potentials to foster future research strategies and therapeutical implications, that might result from them. The term M-D describes <italic>SGCE</italic>-positive M-D in the following, deviations are explicitly stated. Further details on the described studies investigating patients with M-D can be found in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Overview of neurophysiological, imaging, and behavioral/psychophysical studies investigating patients with Myoclonus-Dystonia.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Reference number in the article</th>
<th align="left">Sample characteristic</th>
<th align="left">Control group characteristic</th>
<th align="left">Research method</th>
<th align="left">Experimental tasks</th>
<th align="left">Results</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="6" align="left">Imaging studies</td>
</tr>
<tr>
<td align="left">[<xref ref-type="bibr" rid="B39">39</xref>]</td>
<td align="left">15 <italic>SGCE</italic>-MC (11 pat., 4 AMC)</td>
<td align="left">15 age- and sex-matched HC</td>
<td align="left">[<sup>123</sup>I]-IBZM SPECT</td>
<td align="left">n.a.</td>
<td align="left">Bilateral lower striatal D2R binding in M-D pat. and AMC compared to HC</td>
</tr>
<tr>
<td align="left">[<xref ref-type="bibr" rid="B40">40</xref>]</td>
<td align="left">13&#xa0;M-D pat.</td>
<td align="left">11 age-, and sex-matched HC</td>
<td align="left">fMRI</td>
<td align="left">Finger-tapping task</td>
<td align="left">Hyperresponsiveness in contralateral inferior parietal cortical areas, ipsilateral premotor and primary somatosensory cortex, and the ipsilateral cerebellum in M-D pat. compared to HC</td>
</tr>
<tr>
<td rowspan="2" align="left">[<xref ref-type="bibr" rid="B41">41</xref>]</td>
<td rowspan="2" align="left">16 <italic>SGCE</italic>-MC (8 pat./paternally inherited, 8 AMC/maternally inherited)</td>
<td rowspan="2" align="left">11 HC</td>
<td rowspan="2" align="left">fMRI</td>
<td rowspan="2" align="left">Finger-tapping task</td>
<td align="left">Hyperresponsiveness in the contralateral secondary somatosensory cortex in M-D pat. compared to AMC</td>
</tr>
<tr>
<td align="left">Hyperresponsiveness in the supplementary motor area and the ipsilateral cerebellum in AMC compared to HC</td>
</tr>
<tr>
<td rowspan="2" align="left">[<xref ref-type="bibr" rid="B42">42</xref>]</td>
<td rowspan="2" align="left">25&#xa0;M-D pat.</td>
<td rowspan="2" align="left">25 age-, and gender-matched HC</td>
<td rowspan="2" align="left">Structural MRI (VBM)</td>
<td rowspan="2" align="left">n.a.</td>
<td align="left">No significant differences in gray and white matter volumes between M-D pat. and HC</td>
</tr>
<tr>
<td align="left">In M-D pat., positive correlation of dystonia severity with increased gray matter volume in bilateral putamina</td>
</tr>
<tr>
<td align="left">[<xref ref-type="bibr" rid="B30">30</xref>]</td>
<td align="left">3&#xa0;M-D pat. with GPi-DBS (examined before and approx. 2&#xa0;years after GPi-DBS implantation)</td>
<td align="left">2&#xa0;M-D pat. without GPi-DBS (examined twice, approx. 3.5&#xa0;years apart)</td>
<td align="left">[<sup>123</sup>I]-IBZM SPECT</td>
<td align="left">n.a.</td>
<td align="left">D2R binding was stable in M-D pat. with GPi-DBS after 2&#xa0;years, but reduced in M-D pat. without GPi-DBS after 3.5&#xa0;years</td>
</tr>
<tr>
<td rowspan="5" align="left">[<xref ref-type="bibr" rid="B43">43</xref>]</td>
<td rowspan="5" align="left">12 <italic>SGCE</italic>-MC (6 pat., 6 AMC)</td>
<td rowspan="5" align="left">24 HC, 18 DYT1/<italic>TOR1A</italic> pat., 13 DYT6/<italic>THAP1</italic> pat., 9 dopa-responsive dystonia pat., 7 posthypoxic myoclonus pat.</td>
<td rowspan="5" align="left">[<sup>18</sup>F]-FDG-PET</td>
<td rowspan="5" align="left">n.a.</td>
<td align="left">Metabolic increases in the inferior pons and in the posterior thalamus and reductions in the ventromedial prefrontal cortex in all <italic>SGCE</italic>-MC compared to HC</td>
</tr>
<tr>
<td align="left">Metabolic increases in the parasagittal cerebellum in M-D pat. compared to AMC and HC</td>
</tr>
<tr>
<td align="left">M-D pat. shared metabolic increases in the parasagittal cerebellum with pat. with posthypoxic myoclonus</td>
</tr>
<tr>
<td align="left">M-D pat. shared significant metabolic increases in the superior parietal lobule with all dystonia pat. subgroups</td>
</tr>
<tr>
<td align="left">M-D pat. shared metabolic reductions with DYT1/<italic>TOR1A</italic> pat. in the ventromedial prefrontal cortex</td>
</tr>
<tr>
<td align="left">[<xref ref-type="bibr" rid="B44">44</xref>]</td>
<td align="left">1&#xa0;M-D pat.</td>
<td align="left">1 age-matched HC</td>
<td align="left">fMRI</td>
<td align="left">Motor task (drawing, snapping)</td>
<td align="left">Specific activations within the thalamus and the dentate nucleus of the M-D pat. during the drawing condition with snapping as control, which was not present in the HC</td>
</tr>
<tr>
<td align="left">[<xref ref-type="bibr" rid="B45">45</xref>]</td>
<td align="left">16&#xa0;M-D pat.</td>
<td align="left">18 age-, and sex-matched HC</td>
<td align="left">Structural MRI (white matter VBM, DTI)</td>
<td align="left">n.a.</td>
<td align="left">Increased white matter volume, fractional anisotropy and decreased mean diffusivity in the subthalamic area of the brain stem (including the red nucleus) in M-D pat. compared to HC. Decreased mean diffusivity in the subgyral cortical sensorimotor area in M-D pat. compared to HC</td>
</tr>
<tr>
<td rowspan="4" align="left">[<xref ref-type="bibr" rid="B46">46</xref>]</td>
<td rowspan="4" align="left">24&#xa0;M-D pat. (15 <italic>SGCE</italic>-positive)</td>
<td rowspan="4" align="left">24 gender-, age-, education-, and handedness-matched HC</td>
<td rowspan="4" align="left">fMRI</td>
<td rowspan="4" align="left">Go/No-Go task</td>
<td align="left">Impaired response accuracy in M-D pat. (frequent Go-Inhibit errors/incorrect response-inhibition to Go cues)</td>
</tr>
<tr>
<td align="left">Increased primary motor cortex and insular activation in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">Increased activity in the contralateral thalamus and the dorsolateral prefrontal cortex in M-D pat. during Go-Inhibit trials</td>
</tr>
<tr>
<td align="left">
<italic>SGCE</italic>-positive pat. showed on all contrasts (all possible response trials) hyperactivation in the anterior cerebellum and in the Stop-Respond trial (incorrect response to Stop cue) contrast increased putaminal activation compared to <italic>SGCE</italic>-negative pat.</td>
</tr>
<tr>
<td colspan="6" align="left">Neurophysiological studies</td>
</tr>
<tr>
<td rowspan="2" align="left">[<xref ref-type="bibr" rid="B47">47</xref>]</td>
<td rowspan="2" align="left">2&#xa0;M-D pat. with GPi-DBS</td>
<td rowspan="2" align="left">n.a.</td>
<td rowspan="2" align="left">LFP, EMG</td>
<td rowspan="2" align="left">Motor task &#x26; Go/No-Go task</td>
<td align="left">Increased EMG-GPi-LFP coherence in the 3&#x2013;15&#xa0;Hz frequency band in motor task</td>
</tr>
<tr>
<td align="left">During the Go/No-Go task, synchronization of GPi activity in the 3&#x2013;15&#xa0;Hz frequency band before the cue (Go or No-Go) and desynchronization after the cue</td>
</tr>
<tr>
<td rowspan="2" align="left">[<xref ref-type="bibr" rid="B48">48</xref>]</td>
<td rowspan="2" align="left">20 <italic>SGCE</italic>-MC (15 pat., 5 AMC)</td>
<td rowspan="2" align="left">13 approx. age-, and sex-matched (to the pat.) HC</td>
<td rowspan="2" align="left">EEG-EMG and EMG-EMG coherence</td>
<td rowspan="2" align="left">Rest and contraction of the arm and neck (and, if affected, of the trunk)</td>
<td align="left">Significant 15&#x2013;30&#xa0;Hz EEG-EMG coherence during arm contraction in HC, but not in <italic>SGCE</italic>-MC</td>
</tr>
<tr>
<td align="left">Increased 3&#x2013;10&#xa0;Hz EMG-EMG coherence in M-D pat. with pronounced dystonia</td>
</tr>
<tr>
<td rowspan="2" align="left">[<xref ref-type="bibr" rid="B49">49</xref>]</td>
<td rowspan="2" align="left">6&#xa0;M-D pat.</td>
<td rowspan="2" align="left">9 age-matched HC</td>
<td rowspan="2" align="left">EMG, EEG, TMS, median and digital nerve stimulation</td>
<td rowspan="2" align="left">JLBA, SEP, LLR, RMT, AMT, SICI (rest and active), ICF (rest and active), LICI (rest and active)</td>
<td align="left">JLBA EEG showed no preceding cortical correlates of myoclonus</td>
</tr>
<tr>
<td align="left">Normal LLR to median or digital nerve stimulation, normal SEP, RMT, AMT, SICI, ICF, and LICI in M-D pat. compared to HC</td>
</tr>
<tr>
<td rowspan="3" align="left">[<xref ref-type="bibr" rid="B50">50</xref>]</td>
<td rowspan="3" align="left">9&#xa0;M-D pat.</td>
<td rowspan="3" align="left">HC (not further specified)</td>
<td rowspan="3" align="left">EMG, EEG, TMS</td>
<td rowspan="3" align="left">SEP, VEP, LLR, ERS, ERD, JLBA, RMT, AMT, SICI, LICI, SP, SICF, blink reflex recovery</td>
<td align="left">Normal SEP, VEP, ERD, LLR, SP, RMT, AMT, SICF, and LICI, subtle impairment in SICI, and delayed ERS in the beta band in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">No EEG correlate of myoclonus revealed by JLBA EEG</td>
</tr>
<tr>
<td align="left">In M-D pat., strongly enhanced blink reflex recovery</td>
</tr>
<tr>
<td rowspan="2" align="left">[<xref ref-type="bibr" rid="B51">51</xref>]</td>
<td rowspan="2" align="left">5 <italic>SGCE</italic>-MC (4 pat., 1 AMC)</td>
<td rowspan="2" align="left">10 age-, and handedness-matched HC</td>
<td rowspan="2" align="left">TMS</td>
<td rowspan="2" align="left">AMT, SICI, AI, SICI- and AI-interaction</td>
<td align="left">Higher AMT in <italic>SGCE</italic>-MC compared to HC</td>
</tr>
<tr>
<td align="left">No significant differences between <italic>SGCE</italic>-MC and HC in SICI, AI, and their interaction</td>
</tr>
<tr>
<td rowspan="6" align="left">[<xref ref-type="bibr" rid="B52">52</xref>]</td>
<td rowspan="6" align="left">12&#xa0;M-D pat.</td>
<td rowspan="6" align="left">12 age-, and sex-matched HC</td>
<td rowspan="6" align="left">TMS, motor learning</td>
<td rowspan="6" align="left">(r)RMT, (r)AMT. SICI, SICF, RPAS, EBCC</td>
<td align="left">Normal RMT and AMT in M-D pat. compared to HC using monophasic pulses</td>
</tr>
<tr>
<td align="left">Increased rAMT and borderline increased rRMT, i.e., not significant trend, in M-D pat. compared to HC using biphasic pulses</td>
</tr>
<tr>
<td align="left">Positive correlation of rAMT and rRMT with self-rated global disability score</td>
</tr>
<tr>
<td align="left">No differences in SICI and SICF in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">RPAS effects lasted longer in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">Lower extinction rates in the EBCC task in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">[<xref ref-type="bibr" rid="B2">2</xref>]</td>
<td align="left">41&#xa0;M-D pat.</td>
<td align="left">n.a.</td>
<td align="left">EEG, EMG</td>
<td align="left">Surface polymyography, long-loop C-reflex, JLBA</td>
<td align="left">M-D pat. showed subcortical myoclonus (mean duration 95&#xa0;msec, range 25&#x2013;256&#xa0;msec) at rest, action, and posture, and no cortical hyperexcitability (normal C-reflex response, no short-latency premyoclonic potential)</td>
</tr>
<tr>
<td rowspan="3" align="left">[<xref ref-type="bibr" rid="B53">53</xref>]</td>
<td rowspan="3" align="left">15&#xa0;M-D pat.</td>
<td rowspan="3" align="left">15 gender-, and age-matched HC</td>
<td rowspan="3" align="left">TMS</td>
<td rowspan="3" align="left">RMT, AMT, SP, RC, SICI, ICF, SICF, peripheral median nerve stimulation</td>
<td align="left">Normal RMT, AMT, SP, RC, SICI, and ICF in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">M-D pat. showed more variable and polyphasic MEPs during SICF</td>
</tr>
<tr>
<td align="left">No polyphasic compound muscle action potentials found in M-D pat. and HC with peripheral median nerve stimulation</td>
</tr>
<tr>
<td rowspan="4" align="left">[<xref ref-type="bibr" rid="B54">54</xref>]</td>
<td rowspan="4" align="left">6&#xa0;M-D pat.</td>
<td rowspan="4" align="left">6 primary-generalized dystonia pat.</td>
<td rowspan="4" align="left">Microelectrode recording during GPi-DBS implantation surgery</td>
<td rowspan="4" align="left">n.a.</td>
<td align="left">In M-D pat., higher burst frequency, with a higher burst index, a lower mean burst duration, and a lower interburst interval in GPi neurons, and higher pause frequency in GPe neurons compared with pat. with primary-generalized dystonia</td>
</tr>
<tr>
<td align="left">In M-D pat., significant correlation of GPi activity (mean burst index, burst duration, intraburst frequency and interval, pause and oscillatory frequency) with the preoperative severity of myoclonus</td>
</tr>
<tr>
<td align="left">In M-D pat., significant correlation of preoperative dystonia severity with GPi activity (mean burst duration and pause frequency)</td>
</tr>
<tr>
<td align="left">In primary-generalized dystonia pat., significant correlation of preoperative dystonia severity with GPi activity (mean intraburst frequency and interburst interval) and GPe activity (intraburst frequency)</td>
</tr>
<tr>
<td colspan="6" align="left">Behavioral and psychophysical studies</td>
</tr>
<tr>
<td rowspan="2" align="left">[<xref ref-type="bibr" rid="B55">55</xref>]</td>
<td rowspan="2" align="left">31&#xa0;M-D pat. (12 with GPi-DBS, 21 without GPi-DBS)</td>
<td rowspan="2" align="left">24 matched HC</td>
<td rowspan="2" align="left">Behavioral Task</td>
<td rowspan="2" align="left">Stop signal task</td>
<td align="left">Impaired proactive inhibition in M-D pat. without GPi-DBS (no adaptation to consecutive cues)</td>
</tr>
<tr>
<td align="left">Impaired reactive inhibition in M-D pat. with GPi-DBS (longer stop signal reaction times)</td>
</tr>
<tr>
<td align="left">[<xref ref-type="bibr" rid="B56">56</xref>]</td>
<td align="left">14&#xa0;M-D pat.</td>
<td align="left">14 age- and gender-matched HC</td>
<td align="left">Eye-tracking</td>
<td align="left">Backward saccadic adaptation</td>
<td align="left">Saccadic adaptation was lower and slower in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">[<xref ref-type="bibr" rid="B57">57</xref>]</td>
<td align="left">5&#xa0;M-D pat.</td>
<td align="left">10 age-matched HC</td>
<td align="left">Limb adaptation</td>
<td align="left">Limb adaptation to visuomotor and forcefield pertubation</td>
<td align="left">No difference between M-D pat. and HC</td>
</tr>
<tr>
<td rowspan="2" align="left">[<xref ref-type="bibr" rid="B58">58</xref>]</td>
<td rowspan="2" align="left">23&#xa0;M-D pat.</td>
<td rowspan="2" align="left">25 age-, gender-, and educational level-matched HC</td>
<td rowspan="2" align="left">Tactile sensory information processing</td>
<td rowspan="2" align="left">Tactile TDT, TT</td>
<td align="left">No difference between M-D pat. and HC in TT threshold</td>
</tr>
<tr>
<td align="left">M-D pat. showed increased TDT compared to HC</td>
</tr>
<tr>
<td rowspan="5" align="left">[<xref ref-type="bibr" rid="B59">59</xref>]</td>
<td rowspan="5" align="left">37&#xa0;M-D pat. (24 without GPi-DBS, 13 with GPi-DBS)</td>
<td rowspan="5" align="left">25 HC</td>
<td rowspan="5" align="left">Visual sensory information processing, structural MRI (VBM)</td>
<td rowspan="5" align="left">Visual TDT, orientation of random dot moving task, speed of random dot moving task, ODT, SDT</td>
<td align="left">Higher TDT in M-D pat. with GPi-DBS, compared to HC and M-D pat. without GPi-DBS</td>
</tr>
<tr>
<td align="left">Reduced sensory accumulation for visual information in M-D pat. compared to HC in all tasks</td>
</tr>
<tr>
<td align="left">No differences in ODT and SDT in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">Thicker primary visual cortex (which negatively correlated with TDT performance) and higher gray matter signal of left motor cerebellum (lobules V and VI) in M-D pat. (without GPi-DBS) compared to HC</td>
</tr>
<tr>
<td align="left">Negative correlation of myoclonus severity with TDT performance and positive correlation with left primary visual cortex and bilateral putaminal volumes in M-D pat. (without GPi-DBS)</td>
</tr>
<tr>
<td rowspan="5" align="left">[<xref ref-type="bibr" rid="B60">60</xref>]</td>
<td rowspan="5" align="left">17&#xa0;M-D pat.</td>
<td rowspan="5" align="left">21 age- and sex-matched HC</td>
<td rowspan="5" align="left">Motor learning</td>
<td rowspan="5" align="left">EBCC, blink reflex recovery cycle</td>
<td align="left">Significantly reduced number of conditioned eyeblink responses before alcohol intake in M-D pat. compared to HC</td>
</tr>
<tr>
<td align="left">In M-D pat., negative correlation of action myoclonus severity at baseline with EBCC conditioning response</td>
</tr>
<tr>
<td align="left">Decreased conditioning response rate under alcohol intake in HC</td>
</tr>
<tr>
<td align="left">In M-D pat., increased conditioning response rate under alcohol intake</td>
</tr>
<tr>
<td align="left">No group difference (M-D pat. vs. HC) in blink reflex recovery cycle before and after alcohol intake</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note. Studies are sorted in an alphabetical manner. M-D pat., <italic>SGCE</italic>-positive patients with Myoclonus-Dystonia; pat., patients; <italic>SGCE</italic>, <italic>&#x3b5;-sarcoglycan</italic> gene; GPi, Globus Pallidus internus; DBS, deep-brain stimulation; (A)MC, (asymptomatic) <italic>SGCE</italic> mutation carrier; I-IBZM SPECT, [<sup>123</sup>I]-Iodobenzamide single photon emission computed tomography; n. a., not applicable; D2R, dopamine D2 receptor; HC, healthy control participants; (f)MRI, (functional) magnetic resonance imaging; VBM, voxel based morphometry; DTI, diffusion tensor imaging; FDG-PET, [<sup>18</sup>F]-fluorodeoxyglucose positron-emission tomography; LFP, local field potential; EMG, electromyography; EEG, electroencephalography; TMS, transcranial magnetic stimulation; JLBA, Jerk-locked back-averaging; SEP, somatosensory evoked potentials; VEP, visual evoked potentials; LLR, long-latency reflex; SICI, short-interval intracortical inhibition; (S)ICF, (short-interval) intracortical facilitation; LICI, long-interval intracortical inhibition; ERS, event-related synchronization; ERD, event-related desynchronization; MEP, motor evoked potential; RC, recruitment curve; SP, silent period; (r)AMT, (rapid/biphasic) active motor threshold; AI, afferent inhibition; (r)RMT, (rapid/biphasic) resting motor threshold, RPAS, rapid paired associative stimulation; EBCC, eye-blink classic conditioning; TDT, temporal discrimination threshold; TT, tactile perception threshold; ODT, orientation discrimination threshold; SDT, speed discrimination threshold; GPe, Globus Pallidus externus.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2">
<title>Subcortical alterations in myoclonus-dystonia</title>
<p>Myoclonus in general can have a cortical or a subcortical origin and thus present with different neurophysiological characteristics [<xref ref-type="bibr" rid="B61">61</xref>]. With regards to M-D, the duration of the myoclonic bursts (mean duration 95&#xa0;msec) indicated a subcortical origin [<xref ref-type="bibr" rid="B2">2</xref>], as cortical myoclonus is described with shorter durations between 20 and 50&#xa0;msec [<xref ref-type="bibr" rid="B2">2</xref>]. The hypothesis of a subcortical origin is supported by a lack of cortical hyperexcitability, e.g., absence of giant somatosensory evoked potentials (SEPs) [<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>]. Although, in some patients with M-D myoclonic jerks can be evoked by certain stimuli (e.g., visual, auditory, sensory) [<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>], which could be interpreted as a sign of a cortical source [<xref ref-type="bibr" rid="B62">62</xref>], the stimulus-evoked jerk latency in M-D was consistent with a subcortical origin [<xref ref-type="bibr" rid="B50">50</xref>].</p>
<sec id="s2-1">
<title>Basal ganglia alterations in myoclonus-dystonia</title>
<p>Subcortical alterations were also found with structural and functional imaging techniques. Voxel based morphometry (VBM) studies showed no significant differences in white or gray matter of the basal ganglia in M-D patients, but increased severities of dystonia [<xref ref-type="bibr" rid="B42">42</xref>] and myoclonus [<xref ref-type="bibr" rid="B59">59</xref>] were associated with larger putaminal volumes. Functional imaging with [<sup>18</sup>F]-fluorodeoxyglucose binding revealed genotype related alterations of subcortical metabolic activity in M-D patients and asymptomatic <italic>SGCE</italic>-positive mutation carriers [<xref ref-type="bibr" rid="B43">43</xref>]. Metabolic increases in pontine and thalamic brain areas were present in all <italic>SGCE</italic> mutation carriers compared to healthy controls [<xref ref-type="bibr" rid="B43">43</xref>].</p>
<p>The hypothesis of a subcortical deficit in M-D is also supported by treatment effects in M-D, particularly DBS of the GPi or the VIM [<xref ref-type="bibr" rid="B38">38</xref>], and also by altered activity of GPi neurons [<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B54">54</xref>].</p>
<p>In patients with dystonia, it is thought that the direct motor pathway via striatal D1 receptors is hyperactive, which might result in a reduced GPi activity, and therefore, a disinhibition of the thalamus, and an increased thalamocortical output [<xref ref-type="bibr" rid="B63">63</xref>]. On the other hand, it is suggested that the activity of the indirect motor pathway via striatal D2 receptors is reduced in patients with dystonia [<xref ref-type="bibr" rid="B63">63</xref>]. This explanatory framework might also fit for the hyperkinetic symptoms, e.g., dystonia and myoclonus, present in M-D.</p>
<p>In this regard, an interesting strategy to investigate the hubs of the direct and indirect motor pathways is the use of intracranial DBS electrodes, either intraoperative during DBS implantation surgery or shortly after the operation when the impulse generator is not connected yet and electrodes are externalized. A coherence analysis investigating the synchrony (i.e., correlation) between muscle discharges, recorded with electromyography (EMG), and (motor associated) neural activity, recorded by local field potentials (LFP) of the basal ganglia via DBS electrodes, or cortical activity recorded by electroencephalography (EEG) [<xref ref-type="bibr" rid="B64">64</xref>], is very helpful to draw further conclusions how movements are controlled or influenced by (sub-)cortical activity [<xref ref-type="bibr" rid="B65">65</xref>]. Increased cortico-muscular coherence (3&#x2013;15&#xa0;Hz) between several muscles and the GPi-LFP during rest and voluntary muscle activation was identified in M-D patients after GPi-DBS surgery and could reflect abnormal, e.g., increased GPi activity [<xref ref-type="bibr" rid="B47">47</xref>]. In another study, GPi recordings revealed a higher burst activity, which correlated with a higher preoperative severity of myoclonus in M-D patients in comparison to generalized dystonia patients, and thus seems to be specific for the myoclonus phenotype [<xref ref-type="bibr" rid="B54">54</xref>].</p>
<p>The hypothesis, that hypoactivation of the indirect pathway might contribute to the pathogenesis of M-D, is supported by findings of reduced striatal [<sup>123</sup>I]-Iodobenzamide binding, reflecting lower dopamine D2 receptor binding [<xref ref-type="bibr" rid="B39">39</xref>]. After treatment with GPi-DBS for 2&#xa0;years, striatal dopamine D2 receptor binding did not decrease further, as it was the case in M-D patients without GPi-DBS, suggesting a stabilization on dopamine pathways due to GPi-DBS [<xref ref-type="bibr" rid="B30">30</xref>].</p>
<p>Defective basal ganglia mediated motor inhibition, investigated with a &#x201c;Go/NoGo&#x201d; task, where it is required to react to a &#x201c;Go&#x201d; cue and to suppress a reaction to a &#x201c;NoGo&#x201d; cue, has been found in a group of <italic>SGCE</italic>-positive and <italic>SGCE</italic>-negative M-D patients, suggesting that these abnormalities might be related to phenotype rather than genotype [<xref ref-type="bibr" rid="B46">46</xref>].</p>
<p>The role of the basal ganglia, especially the GPi, during motor inhibition in M-D was further undermined using a &#x201c;stop signal&#x201d; task, which investigates reactive (stop an already started action) and proactive (action inhibition during action preparation) inhibition [<xref ref-type="bibr" rid="B55">55</xref>]. M-D patients with GPi-DBS showed impaired reactive inhibition and M-D patients without GPi-DBS exhibited impaired proactive inhibition [<xref ref-type="bibr" rid="B55">55</xref>]. The impairments in reactive inhibition correlated with the intrinsic/preoperative severity of myoclonus. This could indicate that GPi-DBS on the one hand improves proactive inhibition, but on the other hand impairs reactive inhibition. Moreover, response inhibition involves the hyper-direct and the direct pathway and potentially also the striato-nigral pathway, which is known to be modulated by GPi-DBS [<xref ref-type="bibr" rid="B55">55</xref>].</p>
<p>To sum up, results of neurophysiological, behavioral, and imaging studies, as well as treatment effects of DBS, point to a subcortical deficit in M-D. Especially a dysfunction of the basal ganglia circuits, including the GPi, might contribute to abnormal excitatory output and connectivity with other subcortical and cortical output regions.</p>
</sec>
<sec id="s2-2">
<title>Cerebellar alterations in myoclonus-dystonia</title>
<p>Besides the basal ganglia and its connections, there is emerging evidence that the cerebellum might be involved in the pathogenesis of M-D [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>&#x2013;<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B60">60</xref>]. With regards to structural brain imaging, a VBM study revealed a higher gray matter signal in the left motor cerebellum (lobules V and VI) in M-D patients compared to healthy control participants [<xref ref-type="bibr" rid="B59">59</xref>]. Furthermore, changes of white matter bilateral in subthalamic areas of the brain stem, connecting the cerebellum with the basal ganglia, were observed via VBM and diffusion tensor imaging (DTI) [<xref ref-type="bibr" rid="B45">45</xref>].</p>
<p>Increased metabolic activity in the parasagittal cerebellum has been found in M-D patients, but not in asymptomatic <italic>SCGE</italic>-positive mutation carriers and healthy controls [<xref ref-type="bibr" rid="B43">43</xref>]. Furthermore, these metabolic increases were also found in patients with posthypoxic myoclonus, which was interpreted as phenotype- (i.e., myoclonus) specific cerebellar metabolic abnormality [<xref ref-type="bibr" rid="B43">43</xref>].</p>
<p>In functional magnetic resonance imaging (fMRI) studies using different motor tasks, cerebellar regions were hyperactive in M-D patients [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B46">46</xref>], and asymptomatic <italic>SGCE</italic>-positive mutation carriers, who did not report symptoms by themselves, but had subtle signs of M-D in a detailed motor examination [<xref ref-type="bibr" rid="B41">41</xref>]. These cerebellar hyperactivations might be genotype-specific, as they also allowed separating asymptomatic <italic>SGCE</italic> mutation carriers from healthy controls [<xref ref-type="bibr" rid="B41">41</xref>], and <italic>SGCE</italic>-positive from <italic>SGCE</italic>-negative M-D patients [<xref ref-type="bibr" rid="B46">46</xref>].</p>
<p>Cerebellar function can also be assessed with the help of behavioral tasks, as the cerebellum contributes to non-declarative forms of learning, e.g., motor learning or classical conditioning [<xref ref-type="bibr" rid="B66">66</xref>]. Classical conditioning can be investigated in an experimental setting with an eyeblink conditioning task [<xref ref-type="bibr" rid="B67">67</xref>]. Thereby, the connection between an neutral conditioned stimulus (CS), usually a tone, and a response to be conditioned (conditioned response), a blink (e.g., triggered by an air puff or electrical stimulus) is learned and subsequently unlearned. It is thought, that eyeblink conditioning is mediated via brainstem-cerebellar connections, e.g., between pontine nuclei, the inferior olive, and the cerebellum [<xref ref-type="bibr" rid="B66">66</xref>]. Studies in patients with cerebellar lesions suggest a strong cerebellar involvement in the acquisition of the conditioned response [<xref ref-type="bibr" rid="B66">66</xref>]. Moreover, functional imaging of healthy participants showed activation in the cerebellar lobules VI, Crus I and II, VIIb, VIII, interposed nuclei, and dentate nuclei during acquisition of the conditioned response [<xref ref-type="bibr" rid="B68">68</xref>].</p>
<p>M-D patients showed decreased cerebellar motor learning, reflected by reduced acquisition of the conditioned response, and therefore, a poorer performance in the eyeblink conditioning task [<xref ref-type="bibr" rid="B60">60</xref>]. After consuming alcohol, myoclonus and the acquisition of the conditioned response improved in M-D patients, but decreased in healthy controls [<xref ref-type="bibr" rid="B60">60</xref>]. A proposed mechanism might be, that alcohol probably increases inhibitory GABAergic transmission and improves dysfunctional cerebellar disinhibition in M-D, but disrupts physiological cerebellar activity in the healthy brain [<xref ref-type="bibr" rid="B60">60</xref>]. This hypothesis of an &#x201c;overactive&#x201d;, disinhibited cerebellum might be supported by the fMRI results of cerebellar hyperactivation during motor tasks as described above [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B46">46</xref>].</p>
<p>Contrary to these findings, in another study, a smaller cohort of M-D patients showed normal eyeblink conditioning acquisition/learning rates, but lower extinction rates, i.e., difficulties in unlearning the conditioned response [<xref ref-type="bibr" rid="B52">52</xref>]. Methodological differences (air vs. electrical stimulation, trial numbers) and differences in sample size and characteristics should be kept in mind, when interpreting and comparing results [<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B60">60</xref>].</p>
<p>Other blink reflex measurements such as the blink reflex recovery cycle, which analyzes brain stem-basal ganglia interactions, showed a greater/faster mean recovery [<xref ref-type="bibr" rid="B50">50</xref>]. However, in a larger group of M-D patients, the blink reflex recovery cycle was normal, suggesting normal brain stem-basal ganglia interactions [<xref ref-type="bibr" rid="B60">60</xref>], and a more pronounced cerebellar deficit in M-D [<xref ref-type="bibr" rid="B60">60</xref>].</p>
<p>Another technique to assess cerebellar motor learning is saccadic adaptation [<xref ref-type="bibr" rid="B56">56</xref>]. Adaptation in general requires learning of an artificially induced movement error [<xref ref-type="bibr" rid="B69">69</xref>]. In the case of saccadic adaptation, a visual target is moved after movement initiation, so a corrective eye movement, i.e., a saccade, must be learned [<xref ref-type="bibr" rid="B69">69</xref>]. In a backward reactive saccade adaptation task, which involves the cerebellar vermis (lobules VI and VII), M-D patients showed slower saccadic adaptation [<xref ref-type="bibr" rid="B56">56</xref>]. Interestingly, impairment in a saccadic adaptation task can also be observed in healthy participants following inhibitory repetitive transcranial magnetic stimulation (rTMS) of the posterior vermis [<xref ref-type="bibr" rid="B70">70</xref>]. This suggests reduced function of the posterior vermis in M-D patients, which is also consistent with the observed metabolic differences along the parasagittal cerebellum in M-D patients as described above [<xref ref-type="bibr" rid="B43">43</xref>].</p>
<p>To test, if potential deficits in cerebellar adaptation function might also affect limb adaptation, visuomotor or forcefield perturbation in symptomatic body parts was examined [<xref ref-type="bibr" rid="B57">57</xref>]. In comparison to the deficits in saccadic adaptation [<xref ref-type="bibr" rid="B56">56</xref>], no differences were found in other tasks, suggesting that deficits in saccadic adaptation are not easily translatable to other body regions. However, potential deficits in limb adaptation might be more subtle and need to be investigated in larger sample sizes, as the current study only included five patients [<xref ref-type="bibr" rid="B57">57</xref>]. Also, methodological differences, and the potential contribution of different brain regions have to be kept in mind [<xref ref-type="bibr" rid="B57">57</xref>].</p>
<p>The association between the cerebellum and motor learning deficits in M-D is also supported by results from a paternally-inherited cerebellar Purkinje cell-specific <italic>Sgce</italic> conditional knockout mouse model [<xref ref-type="bibr" rid="B71">71</xref>]. These mice showed motor learning deficits, whereby, paternally-inherited <italic>Sgce</italic> heterozygous (non-conditional) knockout mice showed additional myoclonus, psychiatric alterations (depression- and anxiety-like behaviors), and motor impairments [<xref ref-type="bibr" rid="B72">72</xref>]. This might be an indication, that an impairment of motor learning is mostly influenced by a loss of function of cerebellar <italic>SGCE</italic>, whereas defective <italic>SGCE</italic> in other brain regions might contribute to the development of other symptoms of M-D, like myoclonus [<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>].</p>
<p>In conclusion, although the cerebellum (and its connections to other brain areas) is recognized as a region of particular interest in M-D, its contribution to M-D symptoms remains largely unclear. Imaging data showed that the cerebellum is a promising region to discriminate between <italic>SGCE</italic>-positive mutation carriers and healthy controls, and <italic>SGCE</italic>-positive and <italic>SGCE</italic>-negative M-D patients. In addition, behavioral tasks such as eye-blink conditioning and saccadic adaptation are an important research strategy as they are less prone to motion artefacts than imaging data and can be used in patients who are not suitable for MRI.</p>
</sec>
<sec id="s2-3">
<title>Subcortical-cortical network alterations in myoclonus-dystonia</title>
<p>There is emerging evidence, that dystonias are sensorimotor disorders, as evidences, for instance, by sensory phenomena including symptom improvement by sensory tricks [<xref ref-type="bibr" rid="B73">73</xref>], or increased temporal discrimination thresholds, even in unaffected relatives of patients [<xref ref-type="bibr" rid="B74">74</xref>]. The cerebellum itself is involved in somatosensory processing, as it receives somatosensory input via the spinal cord, visual and auditory systems, and trigeminal nuclei [<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>]. It monitors and adjusts executed movements by comparing planned movements (efference copy) and somatosensory feedback [<xref ref-type="bibr" rid="B76">76</xref>]. Thus, sensory deficits found in M-D might be influenced by cerebellar and basal ganglia dysfunction in M-D.</p>
<p>In this regard, in addition to motor learning and motor inhibition difficulties, M-D patients have also shown sensory abnormalities in the visual and tactile domain [<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>].</p>
<p>Visual sensory processing seems to be impaired in M-D patients with GPi-DBS, who had higher visual temporal discrimination thresholds than M-D patients without GPi-DBS and healthy control participants [<xref ref-type="bibr" rid="B59">59</xref>]. Sensory accumulation, which is a computational analysis of the response times connected to the gain of visual sensory information, was lower in the whole M-D patient group compared to healthy controls in the visual temporal discrimination task, and also in a movement orientation and a movement speed discrimination task [<xref ref-type="bibr" rid="B59">59</xref>]. Patients with more severe myoclonus showed lower sensory accumulation in the visual temporal discrimination task, and had a thicker primary visual cortex. Because the deficits in visual sensory processing were correlated with the thickness of the primary visual cortex, a brain area elementary responsible for visual perception, the authors interpreted these abnormalities as a primary part of M-D, and not as a secondary phenomenon [<xref ref-type="bibr" rid="B59">59</xref>]. Moreover, the role of tactile sensory processing in M-D is underscored by another study, which showed increased tactile temporal discrimination thresholds with preserved tactile perception thresholds in these patients [<xref ref-type="bibr" rid="B58">58</xref>].</p>
<p>Furthermore, besides cerebellar hyperactivation during motor tasks (as described above), hyperactivation of the somatosensory cortex was found in M-D patients [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>], and further separated them from asymptomatic <italic>SGCE</italic> mutation carriers [<xref ref-type="bibr" rid="B41">41</xref>].</p>
<p>Moreover, the cerebellum is also connected with the motor cortex via dentato-thalamo-cortical pathways that are predominantly facilitatory, whereas connections between cerebellar Purkinje cells and the dentate nucleus are inhibitory [<xref ref-type="bibr" rid="B77">77</xref>].</p>
<p>Abnormal cerebellar activity could potentially influence the motor cortex, which could result in defective motor cortex and corticospinal excitability.</p>
<p>Transcranial magnetic stimulation (TMS), a non-invasive brain stimulation technique, is suitable to investigate cerebellar-primary motor cortex connections. The majority of studies analyzed motor cortex excitability by measuring resting or active motor thresholds [<xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B53">53</xref>], or intracortical inhibitory processes [<xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B53">53</xref>].</p>
<p>Measures at rest were normal in M-D across studies, e.g., resting motor threshold [<xref ref-type="bibr" rid="B52">52</xref>] and recruitment curve of motor evoked potentials [<xref ref-type="bibr" rid="B53">53</xref>]. Measures with muscular preactivation, e.g., active motor threshold, were normal [<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>], or, in contrast, increased [<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>]. Myoclonic symptoms, as a part of M-D, appear more frequently during action compared to rest [<xref ref-type="bibr" rid="B38">38</xref>]. The increased active motor thresholds, reflecting a reduced excitability of the axon membranes during muscle activation [<xref ref-type="bibr" rid="B52">52</xref>], might show, that the deficit in M-D is action-specific. In the context of the hypothesis of abnormal cerebellar hyperactivation, increased active motor thresholds could reflect increased Purkinje cell inhibition on the deep cerebellar nuclei, and therefore, an enhanced inhibition of the motor cortex [<xref ref-type="bibr" rid="B76">76</xref>], reflected by increased active motor thresholds. On the other hand, if human M-D is associated with a dysfunction, e.g., decreased activity, of cerebellar Purkinje cells, it might also reduce the inhibition of the dentate nucleus, and therefore, increase the faciliatory cerebellar-thalamo-cortical loop and its excitatory output on the motor cortex. Although this would fit with the hypothesis of cerebellar hyperactivation and the hyperkinetic symptoms of M-D, i.e., myoclonic jerks and dystonia, it does not explain increased active motor thresholds. However, contradictory findings might also be explained with methodological differences, as, e.g., the increased active motor thresholds have only been found using biphasic TMS pulses in one study [<xref ref-type="bibr" rid="B52">52</xref>]. Additionally, motor thresholds might not be sensitive enough to reveal potential (subtle) network deficits [<xref ref-type="bibr" rid="B78">78</xref>].</p>
<p>The majority of other TMS protocols investigating short-interval intracortical inhibition [<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B51">51</xref>&#x2013;<xref ref-type="bibr" rid="B53">53</xref>] and (short-interval) intracortical facilitation [<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>] were normal in different groups of M-D patients, suggesting intact cortical GABA<sub>A</sub>ergic inhibitory and glutaminergic excitatory networks in M-D [<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>]. In addition, GABA<sub>B</sub>ergic inhibitory networks during action and rest [<xref ref-type="bibr" rid="B81">81</xref>&#x2013;<xref ref-type="bibr" rid="B83">83</xref>], investigated with silent periods [<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B53">53</xref>] and long-interval intracortical inhibition [<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>], seem to be normal in M-D patients as well.</p>
<p>The above described method of coherence, referring to EMG-LFP investigations [<xref ref-type="bibr" rid="B47">47</xref>], can also be non-invasively applied with either the combination of EMG and EEG (to analyze cortico-muscular coherence) or of two EMG channels (to analyze intermuscular coherence), if, e.g., the application of an EEG is not possible due to data contamination because of muscle artifacts [<xref ref-type="bibr" rid="B64">64</xref>]. The investigations of EEG-EMG and EMG-EMG coherence can give insights into potentially altered (sub-) cortical neuronal activity, as different oscillations have different neuronal generators, e.g., the olivo-cerebellar system with frequencies between 6&#x2013;12&#xa0;Hz, and the primary motor cortex with frequencies between 15&#x2013;30&#xa0;Hz and 30&#x2013;60&#xa0;Hz [<xref ref-type="bibr" rid="B64">64</xref>].</p>
<p>In a group of M-D patients and non-affected <italic>SGCE</italic> mutation carriers, physiological EEG-EMG coherence in the 15&#x2013;30&#xa0;Hz frequency band was absent during muscular contractions [<xref ref-type="bibr" rid="B48">48</xref>]. This altered cortical activity may be influenced by subcortical dysfunction [<xref ref-type="bibr" rid="B48">48</xref>]. Furthermore, phenotype-specific alterations of intramuscular coherence, i.e., a significantly increased EMG-EMG coherence (3&#x2013;10&#xa0;Hz), were present in M-D patients with pronounced dystonia, but not in those with mild dystonia and/or predominating myoclonus [<xref ref-type="bibr" rid="B48">48</xref>]. This might indicate altered subcortical activity, as increased EMG-GPi-LFP coherence was found in M-D patients as well (as previously reported), suggesting abnormal GPi activity [<xref ref-type="bibr" rid="B47">47</xref>]. With regards to the hypothesis of cerebellar hyperactivation in M-D, the increased coherence might also be influenced by altered olivo-cerebellar oscillations, because these occur at a similar frequency as those associated with increased coherence in M-D [<xref ref-type="bibr" rid="B64">64</xref>].</p>
<p>Overall, M-D patients show sensory dysfunction, reflected by altered visual and tactile processing on a behavioral level, and structural and functional imaging abnormalities. TMS results point towards an action-specific network deficit. Cortical GABA<sub>A</sub>- and GABA<sub>B</sub>ergic inhibitory networks, and excitatory glutaminergic networks seem to be unaffected in M-D. Abnormal cortico- and intermuscular coherence in M-D might be a consequence of altered subcortical activity.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion of the reviewed literature and future perspectives</title>
<p>Behavioral, neurophysiological, and imaging studies in patients with M-D are scarce, used different modalities/protocols, and, thus, revealed partially heterogeneous results. Nevertheless, several studies point towards subcortical abnormalities, e.g., alterations of the cerebellum, the basal ganglia and their connections. However, so far, it remains unclear whether the described abnormalities are causal influencing other brain areas, e.g., the sensorimotor cortex, via cerebello-basal ganglia-thalamo-cortical connections, or whether the findings are a consequence of myoclonus and dystonia.</p>
<p>The cerebellum is linked with the basal ganglia, e.g., the cerebellar cortex is connected with the STN, and the dentate nucleus is directly connected with the substantia nigra and the GPi [<xref ref-type="bibr" rid="B84">84</xref>]. Thus, abnormal cerebellar activity might have a direct influence on the basal ganglia and <italic>vice versa</italic> [<xref ref-type="bibr" rid="B84">84</xref>]. Results from studies in non-human primates and rodents provide support, that cerebellar output mainly targets the indirect pathway of the basal ganglia [<xref ref-type="bibr" rid="B85">85</xref>]. Injection of rabies virus into the putamen and external segment of the globus pallidus (GPe) of macaques revealed a disynaptic connection between the output of the dentate nucleus and the striatum, and a trisynaptic connection with the GPe likely via intralaminar nuclei and/or the ventroanterior/-lateral thalamus [<xref ref-type="bibr" rid="B86">86</xref>]. Therefore, basal ganglia abnormalities in M-D might be influenced by abnormal cerebellar activity or <italic>vice versa</italic>.</p>
<p>To answer the question, if (cerebellar) alterations are a phenotype- or genotype-specific consequence, it is important to include asymptomatic <italic>SGCE</italic> mutation carriers and/or patients with myoclonus and/or dystonic features without <italic>SGCE</italic> mutations. This has been done previously in a few studies, however, the sample sizes were rather small and direct comparisons of the different groups were mostly missing, complicating statistical evaluation and interpretability of the results. One imaging study compared patients with M-D with other patient groups, e.g., with different genetic forms of dystonia, posthypoxic myoclonus, and also with asymptomatic <italic>SGCE</italic> mutation carriers [<xref ref-type="bibr" rid="B43">43</xref>]. The identified shared or delineating metabolic abnormalities are a meaningful example to define phenotype- or genotype-associated characteristics of M-D, e.g., myoclonus-associated increases in the parasagittal cerebellum, which were found in <italic>SGCE</italic>-positive M-D patients and not in asymptomatic <italic>SGCE</italic> mutation carriers on the one hand, and were shared with patients with posthypoxic myoclonus on the other hand [<xref ref-type="bibr" rid="B43">43</xref>]. Comparisons to other cerebellar disorders such as ataxia, cerebellar stroke, and essential tremor would be interesting to better understand potential cerebellar deficits in M-D. Moreover, it would be interesting to compare patients with the M-D phenotype but other monogenic causes, i.e., different pathogenic variants in <italic>SGCE, VPS16, KCTD17</italic>, and others genes [<xref ref-type="bibr" rid="B20">20</xref>], to further analyze phenotype- and genotype-associated mechanisms.</p>
<p>With regards to the clinical characterization of affected patients, it would be preferable to use video rating by movement disorders specialists, who are blinded with regards to genetic status, disease group, and treatment. This could be supplemented by sensor-based technology [<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>], such as accelerometry or electromyography, and also video-based technology with infra-red cameras or subsequent video evaluation with artificial intelligence [<xref ref-type="bibr" rid="B89">89</xref>], to render clinical assessment more objective and to potentially identify more subtle abnormalities, e.g., in asymptomatic mutation carriers, or of symptom characteristics that cannot be assessed reliably on clinical grounds alone, e.g., the duration of myoclonic jerks.</p>
<p>Results of imaging studies partly revealed conflicting results, as some studies found, e.g., differences in gray and/or white matter, whereas others did not. One explanation might be heterogenous phenotypic presentation of M-D given that patients with the same mutation can have different symptoms. Even in the absence of structural abnormalities in M-D patients compared to healthy controls, correlations between symptom severity and putaminal volume have been reported [<xref ref-type="bibr" rid="B42">42</xref>]. Such correlations might be more sensitive markers of phenotype-specific alterations than volume <italic>per se</italic>. Another explanation might be, that especially with imaging techniques, severely affected M-D patients, e.g., those with severe cervical or mobile dystonia, and/or severe myoclonus, are difficult to examine. Subclinical alterations of neural volume in less affected patients, which might be associated with M-D, but were still normal (i.e., not significantly different) compared to healthy controls, might reach significance through correlation analysis with clinical data, and the inclusion of more severely affected patients.</p>
<p>However, especially when arguing for larger M-D cohorts including patients with more severe phenotypes, the technical difficulties, i.e., artifacts in the data collection, due to the hyperkinetic motor symptoms and psychiatric comorbidities such as anxiety disorders, which can additionally hinder data collection, have to be considered when interpreting study results.</p>
<p>Small sample sizes, as seen in most M-D studies, are usually accompanied with low statistical power of results, which reduces the likelihood that a statistically significant effect is a &#x201c;true&#x201d; effect and <italic>vice versa</italic> [<xref ref-type="bibr" rid="B90">90</xref>]. Also, if an underpowered study finds a true effect, it is likely that the size of the effect is exaggerated, which has been referred to as &#x201c;effect inflation&#x201d; or &#x201c;the winners curse&#x201d; [<xref ref-type="bibr" rid="B90">90</xref>]. This can effect replication studies, which calculate their sample sizes with the inflated effect size and then find smaller effects, which are closer to the true effect sizes [<xref ref-type="bibr" rid="B90">90</xref>]. Effect inflation might also have happened in the reviewed literature, as effects found in studies with smaller sample sizes could not be replicated in studies with larger sample sizes and <italic>vice versa</italic>, e.g., studies investigating the blink-reflex recovery cycle and saccadic- and limb-adaptation [<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B60">60</xref>].</p>
<p>Moreover, effects of certain pharmacological drugs and alcohol on symptoms and brain excitability/connectivity alterations have not sufficiently been examined in M-D. Except for one study investigating the clinical and neurophysiologic effects of alcohol in M-D [<xref ref-type="bibr" rid="B60">60</xref>], there are no studies looking at the efficacy of pharmacological therapies in modulating neurophysiological or imaging characteristics. However, M-D patients with GPi-DBS have been examined neurophysiologically and compared to patients without GPi-DBS [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B59">59</xref>]. Longitudinal comparisons of patients pre and post DBS with longer follow-up periods after implantation are desirable, as described, for example, in the study investigating striatal D2 receptor binding [<xref ref-type="bibr" rid="B30">30</xref>]. Moreover, research on patients during implantation and/or with externalized electrodes can provide further insights in the activity of subcortical hubs of the motor network and also of direct DBS effects. However, the additional load and risks for patients have to be kept in mind.</p>
<p>Most M-D studies were unimodal, i.e., used only one technique, e.g., either imaging, behavioral, or one particular neurophysiological paradigm. Studies with multimodal approaches are largely missing, but could be helpful to obtain further clinical/behavioral-neurophysiological/imaging-genotypic correlations.</p>
<p>Identifying abnormal neuronal, e.g., cerebellar/basal ganglia activity either as being causal or as a consequence of symptoms in M-D, does not only give us a chance to further understand the pathophysiology of M-D but also to identify potential targets for non-invasive neuromodulation techniques, e.g., for M-D patients who are not eligible for DBS. Neuromodulation techniques make use of inducing neuronal plasticity, and therefore, modifying neuronal activity via, e.g., rTMS or transcranial electrical stimulation [<xref ref-type="bibr" rid="B91">91</xref>]. In different groups of patients with dystonia, neuronal plasticity seems to be increased [<xref ref-type="bibr" rid="B91">91</xref>].</p>
<p>In this regard, non-invasive brain stimulation techniques can be used to influence the excitability of brain regions such as the VIM, the GPi, or the cerebellum. As the VIM and the GPi are hard to reach by non-invasive stimulation, transcranial focused ultrasound protocols, either as an ablation or as a neuromodulation method, might be an interesting alternative [<xref ref-type="bibr" rid="B92">92</xref>]. A recently published study, examining patients with tremor-dominant Parkinson&#x2019;s disease or essential tremor, showed that high-intensity MRI-guided focused ultrasound ablation of the VIM reduced tremor and was also associated with functional reorganization of specific cerebellar regions, and therefore, alterations of the cerebello-thalamo-cortical network [<xref ref-type="bibr" rid="B93">93</xref>]. With regards to more superficial brain regions like the posterior cerebellum, also transcranial electrical and magnetic stimulation devices could be used to alter cerebellar excitability and thus influence cerebellar output [<xref ref-type="bibr" rid="B94">94</xref>&#x2013;<xref ref-type="bibr" rid="B96">96</xref>]. Transcranial electrical stimulation, which can be fixed to the participants head, can be a reasonable alternative to stimulate hyperkinetic patients such as M-D. Different cerebellar stimulation techniques have been extensively evaluated in healthy participants, with cerebellar transcranial alternating current stimulation appearing to be the most robust method to alter cerebellar activity [<xref ref-type="bibr" rid="B94">94</xref>&#x2013;<xref ref-type="bibr" rid="B96">96</xref>] and are currently investigated in M-D.</p>
<p>In summary, cerebellar-basal ganglia-thalamo-cortical networks seem defective in M-D. However, some major questions are still unanswered and justify further research efforts. Till now, it is unclear whether the cerebellum is the major generator causing symptoms, or affected secondarily with other major players causing symptoms. Moreover, it is unsolved whether the neurophysiological and imaging alterations are the cause or the consequence of the phenotype and how they are related to the genotype.</p>
<p>Therefore, future studies should include patients with phenotypes similar to M-D but different monogenic causes. Moreover, larger groups of symptomatic and asymptomatic mutation carriers should be examined in comparison to healthy non-mutation carriers. Modulation of cerebellar activity of these participants via non-invasive plasticity induction could help to analyze the role of the cerebellum further. Furthermore, future studies should ideally aim for a combination of clinical, neurophysiological, and imaging readout parameters. A correlation of clinical improvement with the modifiability of neurophysiological and imaging findings via plasticity induction might be helpful to explore disease-related mechanisms and guide the development of novel non-invasive treatment options.</p>
</sec>
</body>
<back>
<sec id="s4">
<title>Author contributions</title>
<p>FH contributed to data extraction and drafted and corrected the manuscript. SG contributed to data extraction and manuscript revising. AW contributed to data interpretation and to write, correct and revise the manuscript. AM contributed to correcting and revising the manuscript.</p>
</sec>
<sec sec-type="COI-statement" id="s5">
<title>Conflict of interest</title>
<p>AW received funding from the German Research Foundation (DFG, WE5919/2-1, WE 5919/4-1, and FOR2698/2) and the Dystonia Medical Research Foundation. AW received an Edmond J Safra Movement Disorders Research Career Development Award from the Micheal J Fox Foundation. AM received commercial research support from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion; honoraria for lectures from GlaxoSmithKline, Desitin, Teva, Takeda. AM was consultant for Desitin, Admedicum, PTC Therapeutics, Novartis, Barmer; AM was also supported by the Tourette Syndrome Association (Germany), Interessenverband Tourette Syndrom (Germany), CHDI (Kiel, Germany). AM further received academic research support from the German Research Foundation [DFG; projects 1692/3-1, 4-1, SFB 936 and FOR 2698 (project numbers: 396914663, 396577296, and 396474989)] and the European Reference Network&#x2014;Rare Neurological Diseases (ERN&#x2014;RND; Project ID No 739510). He receives royalties for the book Neurogenetics (Oxford University Press) and is on advisory Boards from the German Tourette syndrome Association, the Alliance of patients with chronic rare diseases, and Novartis.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asmus</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gasser</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Dystonia-plus syndromes</article-title>. <source>Eur J Neurol</source> (<year>2010</year>) <volume>17</volume>(<issue>1</issue>):<fpage>37</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-1331.2010.03049.x</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roze</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Apartis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Clot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dorison</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Thobois</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guyant-Marechal</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations</article-title>. <source>Neurology</source> (<year>2008</year>) <volume>70</volume>(<issue>13</issue>):<fpage>1010</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000297516.98574.c0</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanegas</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Marc&#xe9;-Grau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mart&#xed;-S&#xe1;nchez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mellid</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baide-Mairena</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Correa-Vela</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2020</year>) <volume>80</volume>:<fpage>165</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2020.09.023</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correa&#x2010;Vela</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ferrero&#x2010;Turrion</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cazurro&#x2010;Guti&#xe9;rrez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vanegas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group> <article-title>Early recognition of <italic>SGCE</italic> &#x2010;myoclonus&#x2013;dystonia in children</article-title>. <source>Dev Med Child Neurol</source> (<year>2023</year>) <volume>65</volume>(<issue>2</issue>):<fpage>207</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.15298</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frucht</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Riboldi</surname>
<given-names>GM</given-names>
</name>
</person-group>. <article-title>Alcohol-responsive hyperkinetic movement disorders-a mechanistic hypothesis</article-title>. <source>Tremor Hyperkinetic Mov N Y N</source> (<year>2020</year>) <volume>10</volume>:<fpage>47</fpage>. <pub-id pub-id-type="doi">10.5334/tohm.560</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foncke</surname>
<given-names>EMJ</given-names>
</name>
<name>
<surname>Cath</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zwinderman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Smit</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schmand</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Is psychopathology part of the phenotypic spectrum of myoclonus-dystonia? a study of a large Dutch M-D family</article-title>. <source>Cogn Behav Neurol Off J Soc Behav Cogn Neurol</source> (<year>2009</year>) <volume>22</volume>(<issue>2</issue>):<fpage>127</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1097/WNN.0b013e3181a7228f</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>SJ</given-names>
</name>
<etal/>
</person-group> <article-title>Psychiatric symptoms in myoclonus-dystonia syndrome are just concomitant features regardless of the SGCE gene mutation</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2017</year>) <volume>42</volume>:<fpage>73</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2017.06.014</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peall</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Kurian</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wardle</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Waite</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hedderly</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>SGCE mutations cause psychiatric disorders: clinical and genetic characterization</article-title>. <source>Brain J Neurol</source> (<year>2013</year>) <volume>136</volume>(<issue>1</issue>):<fpage>294</fpage>&#x2013;<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aws308</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peall</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Dijk</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Saunders-Pullman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dreissen</surname>
<given-names>YEM</given-names>
</name>
<name>
<surname>van Loon</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cath</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Psychiatric disorders, myoclonus dystonia and SGCE: an international study</article-title>. <source>Ann Clin Transl Neurol</source> (<year>2016</year>) <volume>3</volume>(<issue>1</issue>):<fpage>4</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/acn3.263</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timmers</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Smit</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuiper</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bartels</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>van der Veen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>van der Stouwe</surname>
<given-names>AMM</given-names>
</name>
<etal/>
</person-group> <article-title>Myoclonus-dystonia: distinctive motor and non-motor phenotype from other dystonia syndromes</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2019</year>) <volume>69</volume>:<fpage>85</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2019.10.015</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timmers</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Peall</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Dijk</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Zutt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Bergmans</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Natural course of myoclonus-dystonia in adulthood: stable motor signs but increased psychiatry</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2020</year>) <volume>35</volume>(<issue>6</issue>):<fpage>1077</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/mds.28033</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Tricht</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Dreissen</surname>
<given-names>YEM</given-names>
</name>
<name>
<surname>Cath</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dijk</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Contarino</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>van der Salm</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group> <article-title>Cognition and psychopathology in myoclonus-dystonia</article-title>. <source>J Neurol Neurosurg Psychiatry</source> (<year>2012</year>) <volume>83</volume>(<issue>8</issue>):<fpage>814</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2011-301386</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weissbach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kasten</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grunewald</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bruggemann</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Trillenberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Prominent psychiatric comorbidity in the dominantly inherited movement disorder myoclonus-dystonia</article-title>. <source>Park Relat Disord</source> (<year>2013</year>) <volume>19</volume>(<issue>4</issue>):<fpage>422</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2012.12.004</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hess</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Aguiar Pde</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Frucht</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shriberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Heiman</surname>
<given-names>GA</given-names>
</name>
<etal/>
</person-group> <article-title>Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers</article-title>. <source>Neurology</source> (<year>2007</year>) <volume>68</volume>(<issue>7</issue>):<fpage>522</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000253188.76092.06</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinugawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vidailhet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Apartis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Grabli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Roze</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Myoclonus-dystonia: an update</article-title>. <source>Mov Disord</source> (<year>2009</year>) <volume>24</volume>(<issue>4</issue>):<fpage>479</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1002/mds.22425</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lane</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sturrock</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rickards</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Understanding psychiatric disorders in idiopathic and inherited (monogenic) forms of isolated and combined dystonia: a systematic review</article-title>. <source>J Neuropsychiatry Clin Neurosci</source> (<year>2021</year>) <volume>33</volume>(<issue>4</issue>):<fpage>295</fpage>&#x2013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1176/appi.neuropsych.20110293</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peall</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Waite</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>HR</given-names>
</name>
</person-group>. <article-title>Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review</article-title>. <source>Mov Disord</source> (<year>2011</year>) <volume>26</volume>(<issue>10</issue>):<fpage>1939</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1002/mds.23791</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders-Pullman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shriberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Heiman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wendt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence</article-title>. <source>Neurology</source> (<year>2002</year>) <volume>58</volume>(<issue>2</issue>):<fpage>242</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.58.2.242</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asmus</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zimprich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Naumann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bertram</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ceballos-Baumann</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Inherited Myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families</article-title>. <source>Ann Neurol</source> (<year>2001</year>) <volume>49</volume>(<issue>1</issue>):<fpage>121</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/1531-8249(200101)49:1&#x3c;121::aid-ana20&#x3e;3.0.co;2-8</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Veen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zutt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marras</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Caviness</surname>
<given-names>JN</given-names>
</name>
<etal/>
</person-group> <article-title>Nomenclature of genetically determined myoclonus syndromes: recommendations of the international Parkinson and movement disorder society task force</article-title>. <source>Mov Disord</source> (<year>2019</year>) <volume>34</volume>(<issue>11</issue>):<fpage>1602</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/mds.27828</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vemula</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Carlisle</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Waite</surname>
<given-names>AJ</given-names>
</name>
<etal/>
</person-group> <article-title>Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome</article-title>. <source>Neurobiol Dis</source> (<year>2017</year>) <volume>98</volume>:<fpage>52</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.11.003</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zimprich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lorenz-Depiereux</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kalscheuer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Asmus</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gasser</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted</article-title>. <source>Eur J Hum Genet EJHG</source> (<year>2003</year>) <volume>11</volume>(<issue>2</issue>):<fpage>138</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5200938</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimprich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grabowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asmus</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Naumann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bertram</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome</article-title>. <source>Nat Genet</source> (<year>2001</year>) <volume>29</volume>(<issue>1</issue>):<fpage>66</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ng709</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Raymond</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Saunders-Pullman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ozelius</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>SGCE myoclonus-dystonia</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Pagon</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Bean</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Gripp</surname>
<given-names>KW</given-names>
</name>
<etal/>
</person-group> editors. <source>GeneReviews&#xae;</source>. <publisher-loc>Seattle (WA)</publisher-loc>: <publisher-name>University of Washington, Seattle</publisher-name> (<year>1993</year>).</citation>
</ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>van Schaik</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Jakobs</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>van Kampen</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Aronica</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MA</given-names>
</name>
<etal/>
</person-group> <article-title>SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?</article-title> <source>Eur J Hum Genet</source> (<year>2011</year>) <volume>19</volume>(<issue>4</issue>):<fpage>438</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2010.206</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerschlager</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Myoclonus</article-title>. <source>Curr Opin Neurol</source> (<year>2009</year>) <volume>22</volume>(<issue>4</issue>):<fpage>414</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0b013e32832d9d4f</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weissbach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saranza</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Combined dystonias: clinical and genetic updates</article-title>. <source>J Neural Transm Vienna Austria</source> (<year>2021</year>) <volume>128</volume>(<issue>4</issue>):<fpage>417</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-020-02269-w</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fearon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Peall</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Vidailhet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fasano</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Medical management of myoclonus-dystonia and implications for underlying pathophysiology</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2020</year>) <volume>77</volume>:<fpage>48</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2020.06.016</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azoulay-Zyss</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roze</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Welter</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yelnik</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clot</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to &#x3b5;-sarcoglycan mutations: a pilot study</article-title>. <source>Arch Neurol</source> (<year>2011</year>) <volume>68</volume>(<issue>1</issue>):<fpage>94</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1001/archneurol.2010.338</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beukers</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Contarino</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Speelman</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Schuurman</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Booij</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MAJ</given-names>
</name>
</person-group>. <article-title>Deep brain stimulation of the pallidum is effective and might stabilize striatal D(2) receptor binding in myoclonus-dystonia</article-title>. <source>Front Neurol</source> (<year>2012</year>) <volume>3</volume>:<fpage>22</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2012.00022</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gruber</surname>
<given-names>D</given-names>
</name>
<name>
<surname>K&#xfc;hn</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Schoenecker</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kivi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Trottenberg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>KT</given-names>
</name>
<etal/>
</person-group> <article-title>Pallidal and thalamic deep brain stimulation in myoclonus-dystonia</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2010</year>) <volume>25</volume>(<issue>11</issue>):<fpage>1733</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1002/mds.23312</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosutzka</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tisch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bonnet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hainque</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Welter</surname>
<given-names>ML</given-names>
</name>
<etal/>
</person-group> <article-title>Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2019</year>) <volume>34</volume>(<issue>1</issue>):<fpage>87</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1002/mds.27474</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krause</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kupsch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gharabaghi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>GH</given-names>
</name>
<etal/>
</person-group> <article-title>Long-term effects of pallidal and thalamic deep brain stimulation in myoclonus dystonia</article-title>. <source>Eur J Neurol</source> (<year>2021</year>) <volume>28</volume>(<issue>5</issue>):<fpage>1566</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1111/ene.14737</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tisch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>KR</given-names>
</name>
</person-group>. <article-title>Pallidal deep brain stimulation for monogenic dystonia: the effect of gene on outcome</article-title>. <source>Front Neurol</source> (<year>2021</year>) <volume>11</volume>:<fpage>630391</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2020.630391</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidailhet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jutras</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Roze</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Grabli</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Deep brain stimulation for dystonia</article-title>. <source>Handb Clin Neurol</source> (<year>2013</year>) <volume>116</volume>:<fpage>167</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-53497-2.00014-0</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X</given-names>
</name>
</person-group>. <article-title>Deep brain stimulation for myoclonus dystonia syndrome: a meta-analysis with individual patient data</article-title>. <source>Neurosurg Rev</source> (<year>2021</year>) <volume>44</volume>:<fpage>451</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s10143-019-01233-x</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>YP</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>JP</given-names>
</name>
</person-group>. <article-title>Thalamus stimulation for myoclonus dystonia syndrome: five cases and long-term follow-up</article-title>. <source>World Neurosurg</source> (<year>2019</year>) <volume>122</volume>:<fpage>e933</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.wneu.2018.10.177</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menozzi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Balint</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Latorre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Rothwell</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>KP</given-names>
</name>
</person-group>. <article-title>Twenty years on: myoclonus-dystonia and &#x3b5;-sarcoglycan - neurodevelopment, channel, and signaling dysfunction</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2019</year>) <volume>34</volume>(<issue>11</issue>):<fpage>1588</fpage>&#x2013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1002/mds.27822</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beukers</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Booij</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weisscher</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zijlstra</surname>
<given-names>F</given-names>
</name>
<name>
<surname>van Amelsvoort</surname>
<given-names>TMJ</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Reduced striatal D2 receptor binding in myoclonus-dystonia</article-title>. <source>Eur J Nucl Med Mol Imaging</source> (<year>2009</year>) <volume>36</volume>(<issue>2</issue>):<fpage>269</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-008-0924-9</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beukers</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Foncke</surname>
<given-names>EMJ</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Nederveen</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>de Ruiter</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Bour</surname>
<given-names>LJ</given-names>
</name>
<etal/>
</person-group> <article-title>Disorganized sensorimotor integration in mutation-positive myoclonus-dystonia: a functional magnetic resonance imaging study</article-title>. <source>Arch Neurol</source> (<year>2010</year>) <volume>67</volume>(<issue>4</issue>):<fpage>469</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1001/archneurol.2010.54</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beukers</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Foncke</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MA</given-names>
</name>
</person-group>. <article-title>Functional magnetic resonance imaging evidence of incomplete maternal imprinting in myoclonus-dystonia</article-title>. <source>Arch Neurol</source> (<year>2011b</year>) <volume>68</volume>(<issue>6</issue>):<fpage>802</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1001/archneurol.2011.23</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beukers</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>van der Salm</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Foncke</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MAJ</given-names>
</name>
</person-group>. <article-title>Severity of dystonia is correlated with putaminal gray matter changes in myoclonus-dystonia</article-title>. <source>Eur J Neurol</source> (<year>2011a</year>) <volume>18</volume>(<issue>6</issue>):<fpage>906</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-1331.2010.03321.x</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carbon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ozelius</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Saunders-Pullman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Frucht</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dhawan</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group> <article-title>Metabolic changes in DYT11 myoclonus-dystonia</article-title>. <source>Neurology</source> (<year>2013</year>) <volume>80</volume>(<issue>4</issue>):<fpage>385</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e31827f0798</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nitschke</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Erdmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Trillenberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sprenger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kock</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sperner</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Functional MRI reveals activation of a subcortical network in a 5-year-old girl with genetically confirmed myoclonus-dystonia</article-title>. <source>Neuropediatrics</source> (<year>2006</year>) <volume>37</volume>(<issue>2</issue>):<fpage>79</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1055/s-2006-924109</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Meer</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Beukers</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>van der Salm</surname>
<given-names>SMA</given-names>
</name>
<name>
<surname>Caan</surname>
<given-names>MWA</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MAJ</given-names>
</name>
<name>
<surname>Nederveen</surname>
<given-names>AJ</given-names>
</name>
</person-group>. <article-title>White matter abnormalities in gene-positive myoclonus-dystonia</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2012</year>) <volume>27</volume>(<issue>13</issue>):<fpage>1666</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25128</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Salm</surname>
<given-names>SMA</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Nederveen</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>van Rootselaar</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MAJ</given-names>
</name>
</person-group>. <article-title>Functional MRI study of response inhibition in myoclonus dystonia</article-title>. <source>Exp Neurol</source> (<year>2013</year>) <volume>247</volume>:<fpage>623</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2013.02.017</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foncke</surname>
<given-names>EMJ</given-names>
</name>
<name>
<surname>Bour</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Speelman</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Koelman</surname>
<given-names>JHTM</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MAJ</given-names>
</name>
</person-group>. <article-title>Local field potentials and oscillatory activity of the internal globus pallidus in myoclonus-dystonia</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2007a</year>) <volume>22</volume>(<issue>3</issue>):<fpage>369</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1002/mds.21284</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foncke</surname>
<given-names>EMJ</given-names>
</name>
<name>
<surname>Bour</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Koelman</surname>
<given-names>JHTM</given-names>
</name>
<name>
<surname>Tijssen</surname>
<given-names>MAJ</given-names>
</name>
</person-group>. <article-title>Abnormal low frequency drive in myoclonus-dystonia patients correlates with presence of dystonia</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2007b</year>) <volume>22</volume>(<issue>9</issue>):<fpage>1299</fpage>&#x2013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1002/mds.21519</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Cunic</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Paradiso</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gunraj</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pal</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AE</given-names>
</name>
<etal/>
</person-group> <article-title>Electrophysiological features of myoclonus-dystonia</article-title>. <source>Mov Disord</source> (<year>2008</year>) <volume>23</volume>(<issue>14</issue>):<fpage>2055</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1002/mds.22273</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Canafoglia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zibordi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ciano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Visani</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zorzi</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome</article-title>. <source>Mov Disord</source> (<year>2008</year>) <volume>23</volume>(<issue>14</issue>):<fpage>2041</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/mds.22256</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meunier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lourenco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Roze</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Apartis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Trocello</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vidailhet</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Cortical excitability in DYT&#x2010;11 positive myoclonus dystonia</article-title>. <source>Mov Disord</source> (<year>2008</year>) <volume>23</volume>(<issue>5</issue>):<fpage>761</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/mds.21954</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Milani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hubsch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brochard</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tranchant</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias</article-title>. <source>JAMA Neurol</source> (<year>2014</year>) <volume>71</volume>(<issue>5</issue>):<fpage>612</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2014.99</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Salm</surname>
<given-names>SMA</given-names>
</name>
<name>
<surname>van Rootselaar</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Foncke</surname>
<given-names>EMJ</given-names>
</name>
<name>
<surname>Koelman</surname>
<given-names>JHTM</given-names>
</name>
<name>
<surname>Bour</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>KP</given-names>
</name>
<etal/>
</person-group> <article-title>Normal cortical excitability in Myoclonus-Dystonia--a TMS study</article-title>. <source>Exp Neurol</source> (<year>2009</year>) <volume>216</volume>(<issue>2</issue>):<fpage>300</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.12.001</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welter</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Grabli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Karachi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jodoin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fernandez-Vidal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brun</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group> <article-title>Pallidal activity in myoclonus dystonia correlates with motor signs</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2015</year>) <volume>30</volume>(<issue>7</issue>):<fpage>992</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26244</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atkinson-Clement</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tarrano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Porte</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Wattiez</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McGovern</surname>
<given-names>EM</given-names>
</name>
<etal/>
</person-group> <article-title>Dissociation in reactive and proactive inhibitory control in Myoclonus dystonia</article-title>. <source>Sci Rep</source> (<year>2020</year>) <volume>10</volume>(<issue>1</issue>):<fpage>13933</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-70926-x</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hubsch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vidailhet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rivaud-P&#xe9;choux</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pouget</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brochard</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Degos</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Impaired saccadic adaptation in DYT11 dystonia</article-title>. <source>J Neurol Neurosurg Psychiatry</source> (<year>2011</year>) <volume>82</volume>(<issue>10</issue>):<fpage>1103</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2010.232793</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadnicka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Galea</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Rothwell</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group> <article-title>Delineating cerebellar mechanisms in DYT11 myoclonus-dystonia</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2018</year>) <volume>33</volume>(<issue>12</issue>):<fpage>1956</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1002/mds.27517</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarrano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lamy</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McGovern</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Atkinson-Clement</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brochard</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group> <article-title>Tactile temporal discrimination is impaired in myoclonus-dystonia</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2020b</year>) <volume>35</volume>(<issue>12</issue>):<fpage>2356</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/mds.28253</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarrano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wattiez</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McGovern</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Brochard</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Thobois</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Visual sensory processing is altered in myoclonus dystonia</article-title>. <source>Mov Disord</source> (<year>2020a</year>) <volume>35</volume>(<issue>1</issue>):<fpage>151</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1002/mds.27857</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weissbach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Werner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bally</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Tunc</surname>
<given-names>S</given-names>
</name>
<name>
<surname>L&#xf6;ns</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Timmann</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Alcohol improves cerebellar learning deficit in myoclonus-dystonia: a clinical and electrophysiological investigation</article-title>. <source>Ann Neurol</source> (<year>2017</year>) <volume>82</volume>(<issue>4</issue>):<fpage>543</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1002/ana.25035</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Veen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Caviness</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Dreissen</surname>
<given-names>YEM</given-names>
</name>
<name>
<surname>Ganos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koelman</surname>
<given-names>JHTM</given-names>
</name>
<etal/>
</person-group> <article-title>Myoclonus and other jerky movement disorders</article-title>. <source>Clin Neurophysiol Pract</source> (<year>2022</year>) <volume>7</volume>:<fpage>285</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1016/j.cnp.2022.09.003</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cassim</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Houdayer</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Neurophysiology of myoclonus</article-title>. <source>Neurophysiol Clin Neurophysiol</source> (<year>2006</year>) <volume>36</volume>(<issue>5</issue>):<fpage>281</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.neucli.2006.10.001</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simonyan</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Neuroimaging applications in dystonia</article-title>. <source>Int Rev Neurobiol</source> (<year>2018</year>) <volume>143</volume>:<fpage>1</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/bs.irn.2018.09.007</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grosse</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cassidy</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>EEG-EMG, MEG-EMG and EMG-EMG frequency analysis: physiological principles and clinical applications</article-title>. <source>Clin Neurophysiol Off J Int Fed Clin Neurophysiol</source> (<year>2002</year>) <volume>113</volume>(<issue>10</issue>):<fpage>1523</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/s1388-2457(02)00223-7</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Corticomuscular coherence and its applications: a review</article-title>. <source>Front Hum Neurosci</source> (<year>2019</year>) <volume>13</volume>:<fpage>100</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2019.00100</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerwig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kolb</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>Timmann</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>The involvement of the human cerebellum in eyeblink conditioning</article-title>. <source>Cerebellum</source> (<year>2007</year>) <volume>6</volume>(<issue>1</issue>):<fpage>38</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1080/14734220701225904</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bracha</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zbarska</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Carrel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zenitsky</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bloedel</surname>
<given-names>JR</given-names>
</name>
</person-group>. <article-title>The cerebellum and eye-blink conditioning: learning versus network performance hypotheses</article-title>. <source>Neuroscience</source> (<year>2009</year>) <volume>162</volume>(<issue>3</issue>):<fpage>787</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.12.042</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Th&#xfc;rling</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kahl</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maderwald</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stefanescu</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Schlamann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boele</surname>
<given-names>HJ</given-names>
</name>
<etal/>
</person-group> <article-title>&#x201c;Cerebellar cortex and cerebellar nuclei are concomitantly activated during eyeblink conditioning: a 7T fMRI study in humans&#x201d;: correction</article-title>. <source>J Neurosci</source> (<year>2017</year>) <volume>37</volume>(<issue>40</issue>):<fpage>9795</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2133-17.2017</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prsa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thier</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>The role of the cerebellum in saccadic adaptation as a window into neural mechanisms of motor learning</article-title>. <source>Eur J Neurosci</source> (<year>2011</year>) <volume>33</volume>(<issue>11</issue>):<fpage>2114</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07693.x</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkinson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Miall</surname>
<given-names>RC</given-names>
</name>
</person-group>. <article-title>Disruption of saccadic adaptation with repetitive transcranial magnetic stimulation of the posterior cerebellum in humans</article-title>. <source>The Cerebellum</source> (<year>2010</year>) <volume>9</volume>(<issue>4</issue>):<fpage>548</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1007/s12311-010-0193-6</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokoi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Doroodchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models</article-title>. <source>Behav Brain Res</source> (<year>2012</year>) <volume>227</volume>(<issue>1</issue>):<fpage>12</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2011.10.024</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokoi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice</article-title>. <source>J Biochem (Tokyo)</source> (<year>2006</year>) <volume>140</volume>(<issue>1</issue>):<fpage>141</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/jb/mvj138</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newby</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Muhamed</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Alty</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cosgrove</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jamieson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Geste antagoniste effects on motor performance in dystonia-A kinematic study</article-title>. <source>Mov Disord Clin Pract</source> (<year>2022</year>) <volume>9</volume>(<issue>6</issue>):<fpage>759</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1002/mdc3.13505</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimmich</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Molloy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Whelan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Balsters</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Temporal discrimination, a cervical dystonia endophenotype: penetrance and functional correlates: temporal Discrimination in Cervical Dystonia</article-title>. <source>Mov Disord</source> (<year>2014</year>) <volume>29</volume>(<issue>6</issue>):<fpage>804</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25822</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75.In:</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name>
<surname>Kandel</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Jessell</surname>
<given-names>T</given-names>
</name>
</person-group>, editors. <source>Principles of neural science</source>. <edition>4 ed</edition>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name> (<year>2000</year>). p. <fpage>1414</fpage>.</citation>
</ref>
<ref id="B76">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roostaei</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nazeri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sahraian</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Minagar</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>The human cerebellum: a review of physiologic neuroanatomy</article-title>. <source>Neurol Clin</source> (<year>2014</year>) <volume>32</volume>(<issue>4</issue>):<fpage>859</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.ncl.2014.07.013</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galea</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Jayaram</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ajagbe</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Celnik</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Modulation of cerebellar excitability by polarity-specific noninvasive direct current stimulation</article-title>. <source>J Neurosci Off J Soc Neurosci</source> (<year>2009</year>) <volume>29</volume>(<issue>28</issue>):<fpage>9115</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2184-09.2009</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Udupa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Motor cortical circuits in Parkinson disease and dystonia</article-title>. <source>Handb Clin Neurol</source> (<year>2019</year>) <volume>161</volume>:<fpage>167</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-64142-7.00047-3</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Lazzaro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Oliviero</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saturno</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dileone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pilato</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nardone</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans</article-title>. <source>J Physiol</source> (<year>2005</year>) <volume>564</volume>(<issue>2</issue>):<fpage>661</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2004.061747</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziemann</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Hallett</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Dextromethorphan decreases the excitability of the human motor cortex</article-title>. <source>Neurology</source> (<year>1998</year>) <volume>51</volume>(<issue>5</issue>):<fpage>1320</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.51.5.1320</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cros</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Curra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Di Lazzaro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lefaucheur</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Magistris</surname>
<given-names>MR</given-names>
</name>
<etal/>
</person-group> <article-title>The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee</article-title>. <source>Clin Neurophysiol Off J Int Fed Clin Neurophysiol</source> (<year>2008</year>) <volume>119</volume>(<issue>3</issue>):<fpage>504</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinph.2007.10.014</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hupfeld</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Fling</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Seidler</surname>
<given-names>RD</given-names>
</name>
</person-group>. <article-title>TMS-induced silent periods: a review of methods and call for consistency</article-title>. <source>J Neurosci Methods</source> (<year>2020</year>) <volume>346</volume>:<fpage>108950</fpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2020.108950</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Werhahn</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Kunesch</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Noachtar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Benecke</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Classen</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans</article-title>. <source>J Physiol</source> (<year>1999</year>) <volume>517</volume>(<issue>2</issue>):<fpage>591</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.0591t.x</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milardi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Arrigo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anastasi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cacciola</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marino</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mormina</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Extensive direct subcortical cerebellum-basal ganglia connections in human brain as revealed by constrained spherical deconvolution tractography</article-title>. <source>Front Neuroanat</source> (<year>2016</year>) <volume>10</volume>:<fpage>29</fpage>. <pub-id pub-id-type="doi">10.3389/fnana.2016.00029</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bostan</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Strick</surname>
<given-names>PL</given-names>
</name>
</person-group>. <article-title>The basal ganglia and the cerebellum: nodes in an integrated network</article-title>. <source>Nat Rev Neurosci</source> (<year>2018</year>) <volume>19</volume>(<issue>6</issue>):<fpage>338</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1038/s41583-018-0002-7</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoshi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>L</given-names>
</name>
<name>
<surname>F&#xe9;ger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Carras</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Strick</surname>
<given-names>PL</given-names>
</name>
</person-group>. <article-title>The cerebellum communicates with the basal ganglia</article-title>. <source>Nat Neurosci</source> (<year>2005</year>) <volume>8</volume>(<issue>11</issue>):<fpage>1491</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/nn1544</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinhardt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Heldmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sprenger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Laabs</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Prodromal X-linked dystonia-parkinsonism is characterized by a subclinical motor phenotype</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2022</year>) <volume>37</volume>(<issue>7</issue>):<fpage>1474</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1002/mds.29033</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berbakov</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jovanovi&#x107;</surname>
<given-names>&#x10c;</given-names>
</name>
<name>
<surname>Svetel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vasiljevi&#x107;</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dimi&#x107;</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Radulovi&#x107;</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Quantitative assessment of head tremor in patients with essential tremor and cervical dystonia by using inertial sensors</article-title>. <source>Sensors</source> (<year>2019</year>) <volume>19</volume>(<issue>19</issue>):<fpage>4246</fpage>. <pub-id pub-id-type="doi">10.3390/s19194246</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Br&#xfc;gge</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Sallandt</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Schappert</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Siekmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grzegorzek</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Automated motor tic detection: a machine learning approach</article-title>. <source>Mov Disord Off J Mov Disord Soc</source> (<year>2023</year>) <volume>38</volume>(<issue>7</issue>):<fpage>1327</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1002/mds.29439</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Button</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Ioannidis</surname>
<given-names>JPA</given-names>
</name>
<name>
<surname>Mokrysz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nosek</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>ESJ</given-names>
</name>
<etal/>
</person-group> <article-title>Power failure: why small sample size undermines the reliability of neuroscience</article-title>. <source>Nat Rev Neurosci</source> (<year>2013</year>) <volume>14</volume>(<issue>5</issue>):<fpage>365</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3475</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lozeron</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Poujois</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Masmoudi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meppiel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Woimant</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>Contribution of TMS and rTMS in the understanding of the pathophysiology and in the treatment of dystonia</article-title>. <source>Front Neural Circuits</source> (<year>2016</year>) <volume>10</volume>:<fpage>90</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2016.00090</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishna</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sammartino</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rezai</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>A review of the current therapies, challenges, and future directions of transcranial focused ultrasound technology: advances in diagnosis and treatment</article-title>. <source>JAMA Neurol</source> (<year>2018</year>) <volume>75</volume>(<issue>2</issue>):<fpage>246</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2017.3129</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dahmani</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Focused ultrasound thalamotomy for tremor treatment impacts the cerebello-thalamo-cortical network</article-title>. <source>NPJ Park Dis</source> (<year>2023</year>) <volume>9</volume>(<issue>1</issue>):<fpage>90</fpage>. <pub-id pub-id-type="doi">10.1038/s41531-023-00543-8</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herzog</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Pauly</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rueckert</surname>
<given-names>E</given-names>
</name>
<name>
<surname>M&#xfc;nchau</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Cerebellar transcranial current stimulation - an intraindividual comparison of different techniques</article-title>. <source>Front Neurosci</source> (<year>2022</year>) <volume>16</volume>:<fpage>987472</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2022.987472</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pauly</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Steinmeier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bolte</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hamami</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tzvi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>M&#xfc;nchau</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Cerebellar rTMS and PAS effectively induce cerebellar plasticity</article-title>. <source>Sci Rep</source> (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>3070</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-82496-7</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herzog</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bolte</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Radecke</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>von M&#xf6;ller</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lencer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tzvi</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Neuronavigated cerebellar 50 Hz tACS: attenuation of stimulation effects by motor sequence learning</article-title>. <source>Biomedicines</source> (<year>2023</year>) <volume>11</volume>(<issue>8</issue>):<fpage>2218</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines11082218</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>